We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CyberArk's Machine Identity Push: Is Venafi the Game Changer?
Read MoreHide Full Article
Key Takeaways
Venafi featured in 9 of CYBR's top 10 Q1 deals, boosting cross-sell momentum across identity security.
A Fortune 100 firm and PDS Health expanded with Venafi, each signing six-figure machine identity deals.
CYBR says machine identities now outnumber human ones 80:1, up from 45:1, expanding its $60B TAM.
CyberArk (CYBR - Free Report) is gaining traction in the fast-growing machine identity market. CyberArk’s acquisition of Venafi, a leader in machine identity management, is emerging as a key growth catalyst. In the first quarter of fiscal 2025, Venafi was included in nine of CyberArk’s top 10 deals. This reinforces Venafi’s position as a key cross-sell driver within CyberArk’s identity security platform.
Early traction is evident in notable wins. A Fortune 100 financial services firm, which is a long-time CyberArk customer on the human identity side, expanded into certificate lifecycle management and Public Key Infrastructure (PKI) offerings with a competitive multi-six-figure Annual Contract Value (ACV) deal. Another notable win includes PDS Health, a customer with CyberArk since 2019. The healthcare support organisation expanded on the machine identity side by deploying all of Venafi’s Certificate Manager and Zero Touch PKI in a six-figure ACV deal during the first quarter.
During the first quarter, management noted that machine identities now outnumber human identities by more than 80 to 1, which is up from a 45:1 ratio just a year ago. This makes machine identities one of the largest and fastest-growing attack surfaces in enterprise IT. With Venafi, CyberArk is addressing these challenges through end-to-end machine identity security, focused on visibility, governance and control.
When the acquisition closed in late 2024, CyberArk estimated that Venafi would expand its total addressable market by $10 billion to approximately $60 billion. As cloud complexity grows and machine identities continue to outnumber humans, Venafi appears well-positioned to become a foundational pillar in CyberArk’s platform-led growth strategy.
How Competitors Fare Against CYBR
CrowdStrike (CRWD - Free Report) and Palo Alto Networks (PANW - Free Report) are also evolving their platforms to meet enterprise security demands.
CrowdStrike is another established player in the identity security space, providing unified, real-time protection across cloud, identity and endpoint. CrowdStrike is enhancing its identity security platform with the implementation of AI copilots like Charlotte AI and agentic AI solutions like Charlotte AI Agentic Workflows.
Palo Alto Networks is doubling down on its platformization strategy. In the third quarter of fiscal 2025, PANW closed more than 90 net new platform deals. Moreover, the number of customers platformized on Cortex was up nearly three times, reflecting strong momentum with Palo Alto Networks’ Extended Security Intelligence and Automation Management or XSIAM security operation platform.
CYBR’s Price Performance, Valuation and Estimates
Shares of CyberArk have gained 19.4% year to date compared with the Zacks Security industry’s growth of 20.2%.
CYBR YTD Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, CYBR trades at a forward price-to-sales ratio of 13.16, below the industry’s 14.5.
CYBR Forward 12-Month P/S Ratio
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CYBR’s 2025 and 2026 earnings implies a year-over-year increase of 25.74% and 25.72%, respectively. The estimates for 2025 and 2026 have been revised downward over the past seven days.
Image: Bigstock
CyberArk's Machine Identity Push: Is Venafi the Game Changer?
Key Takeaways
CyberArk (CYBR - Free Report) is gaining traction in the fast-growing machine identity market. CyberArk’s acquisition of Venafi, a leader in machine identity management, is emerging as a key growth catalyst. In the first quarter of fiscal 2025, Venafi was included in nine of CyberArk’s top 10 deals. This reinforces Venafi’s position as a key cross-sell driver within CyberArk’s identity security platform.
Early traction is evident in notable wins. A Fortune 100 financial services firm, which is a long-time CyberArk customer on the human identity side, expanded into certificate lifecycle management and Public Key Infrastructure (PKI) offerings with a competitive multi-six-figure Annual Contract Value (ACV) deal. Another notable win includes PDS Health, a customer with CyberArk since 2019. The healthcare support organisation expanded on the machine identity side by deploying all of Venafi’s Certificate Manager and Zero Touch PKI in a six-figure ACV deal during the first quarter.
During the first quarter, management noted that machine identities now outnumber human identities by more than 80 to 1, which is up from a 45:1 ratio just a year ago. This makes machine identities one of the largest and fastest-growing attack surfaces in enterprise IT. With Venafi, CyberArk is addressing these challenges through end-to-end machine identity security, focused on visibility, governance and control.
When the acquisition closed in late 2024, CyberArk estimated that Venafi would expand its total addressable market by $10 billion to approximately $60 billion. As cloud complexity grows and machine identities continue to outnumber humans, Venafi appears well-positioned to become a foundational pillar in CyberArk’s platform-led growth strategy.
How Competitors Fare Against CYBR
CrowdStrike (CRWD - Free Report) and Palo Alto Networks (PANW - Free Report) are also evolving their platforms to meet enterprise security demands.
CrowdStrike is another established player in the identity security space, providing unified, real-time protection across cloud, identity and endpoint. CrowdStrike is enhancing its identity security platform with the implementation of AI copilots like Charlotte AI and agentic AI solutions like Charlotte AI Agentic Workflows.
Palo Alto Networks is doubling down on its platformization strategy. In the third quarter of fiscal 2025, PANW closed more than 90 net new platform deals. Moreover, the number of customers platformized on Cortex was up nearly three times, reflecting strong momentum with Palo Alto Networks’ Extended Security Intelligence and Automation Management or XSIAM security operation platform.
CYBR’s Price Performance, Valuation and Estimates
Shares of CyberArk have gained 19.4% year to date compared with the Zacks Security industry’s growth of 20.2%.
CYBR YTD Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, CYBR trades at a forward price-to-sales ratio of 13.16, below the industry’s 14.5.
CYBR Forward 12-Month P/S Ratio
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CYBR’s 2025 and 2026 earnings implies a year-over-year increase of 25.74% and 25.72%, respectively. The estimates for 2025 and 2026 have been revised downward over the past seven days.
Image Source: Zacks Investment Research
CyberArk currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.